Could a probiotic slow Alzheimer's? new study seeks answers
NCT ID NCT07496021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a probiotic called L. lactis CKDB001 can safely slow memory and thinking decline in people with early Alzheimer's disease. About 60 adults aged 55–85 with mild symptoms and positive amyloid brain scans will receive either the probiotic or a placebo for 24 weeks. Researchers will measure changes in cognition, daily function, and brain biomarkers to see if the treatment has any benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ALZHEIMERS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yonsei University Severance Hospital
RECRUITINGSeoul, South Korea
-
Yonsei University Yongin Severance Hospital
RECRUITINGGyeonggi-do, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.